LEFP
GSK icon

Leading Edge Financial Planning’s GSK GSK Stock Holding History

Leading Edge Financial Planning’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,759
Closed -$209K – 63
2023
Q3 		$209K Sell
5,759
-3
-0.1% -$106 0.13% 63
2023
Q2 		$205K Hold
5,762
– – 0.13% 65
2023
Q1 		$205K Hold
5,762
– – 0.15% 65
2022
Q4 		$202K Buy
+5,762
New +$192K 0.18% 63

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Leading Edge Financial Planning's GSK Position: Q4 2023 in Review

Leading Edge Financial Planning sold out of GSK (GSK) in Q4 2023, closing a stake of 5,759 shares — an estimated $209K sold.

Leading Edge Financial Planning first reported a position in GSK in Q4 2022 and held it in 4 quarters. The position peaked at $209K in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Leading Edge Financial Planning reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
  • Leading Edge Financial Planning sold 5,759 GSK shares in Q4 2023, an estimated $209K.
  • Leading Edge Financial Planning first reported a position in GSK in Q4 2022 and held it in 4 quarters.
  • Leading Edge Financial Planning's GSK position peaked at $209K in Q3 2023.
  • 895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Leading Edge Financial Planning's 13F filing for Q4 2023, filed 13 Feb 2024.